EIKN EIKON THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 9 analyst firms say about EIKON THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on EIKN from 4 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wedbush lowered its target from $5.00 (set 12 May 2026) to $4.00 on 14 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Jason Zemansky | Buy | 2 Mar 2026 | 34.00 USD |
| Cantor Fitzgerald | Imogen Mansfield | Buy | 2 Jun 2026 | — |
| H.C. Wainwright | Sara Nik | Buy | 16 Oct 2026 | 23.00 USD |
| JPMorgan | Brian Cheng | Buy | 2 Mar 2026 | 29.00 USD |
| Mizuho | Graig Suvannavejh | Buy | 16 Sep 2026 | 26.00 USD |
| Morgan Stanley | Sean Laaman | Buy | 2 Mar 2026 | 32.00 USD |
| Wedbush | Robert Driscoll | Sell | 14 Aug 2026 | 4.00 USD |
| Weiss Ratings | Unnamed analyst | — | 3 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 27 Feb 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.